Inactive Instrument

Company Tibet Pharmaceuticals, Inc. Other OTC

Equities

TBET

VGG886151023

Pharmaceuticals

Business Summary

Tibet Pharmaceuticals, Inc., formerly Shangri-La Tibetan Pharmaceuticals, Inc., is a specialty pharmaceutical company focusing on the research, development, manufacturing and marketing of Tibetan medicines. The Company sells both prescription and over-the-counter traditional Tibetan medicines. As of December 31, 2009, it had developed five pharmaceutical products. The Company sells its products principally to distributors in People's Republic of China, who in turn sell them to hospitals, hospital pharmacies and retail pharmacies. The Company’s products include 25 Ingredients Mandrake Pill, 28 Ingredients Pinang Pill, 18 Ingredients Chebulic (Myrobalan) Frusemide Pill, 15 Ingredients Gentiana Pill and Pomegranate Nichirin Pill.

Sales per Business

USD in Million2009Weight2010Weight Delta
Tibetan Medicines
100.0 %
23 100.0 % 32 100.0 % +40.67%

Sales per region

USD in Million2009Weight2010Weight Delta
China
100.0 %
23 100.0 % 32 100.0 % +40.67%

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 14,845,834 14,845,834 ( 100.00 %) 0 100.00 %

Company contact information

Tibet Pharmaceuticals, Inc.

53 Niwang Road Shangri-La County

674400, Diqing

+

address Tibet Pharmaceuticals, Inc.(TBET)
  1. Stock Market
  2. Equities
  3. TBET Stock
  4. TBET Stock
  5. Company Tibet Pharmaceuticals, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW